antibodies against vegf  (Abcam)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 99
    Name:
    Anti VEGFA antibody
    Description:

    Catalog Number:
    AB46154
    Price:
    None
    Buy from Supplier


    Structured Review

    Abcam antibodies against vegf
    Protein expression of <t>VEGF</t> and <t>PEDF</t> in the xanthatin group and the control group. (A) Representative fluorescence microscopy images showing expression of VEGF and PEDF and their localization in the alkali-burned rat corneas of the xanthatin treatment group and the control group on day 14. (B) Quantification of expression levels of VEGF and PEDF in the xanthatin treatment group and the control group was performed using ImageJ software. (C) Western blot bands of protein expression of VEGF and PEDF in the alkali-burned rat corneas of the xanthatin treatment group and the control group on day 14 are shown. (D) Histograms representing the relative levels of VEGF and PEDF, respectively, in the xanthatin treatment group and the control group. Data are presented as the mean ± standard deviation from three independent experiments. * P

    https://www.bioz.com/result/antibodies against vegf/product/Abcam
    Average 99 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    antibodies against vegf - by Bioz Stars, 2021-04
    99/100 stars

    Images

    1) Product Images from "Xanthatin inhibits corneal neovascularization by inhibiting the VEGFR2-mediated STAT3/PI3K/Akt signaling pathway"

    Article Title: Xanthatin inhibits corneal neovascularization by inhibiting the VEGFR2-mediated STAT3/PI3K/Akt signaling pathway

    Journal: International Journal of Molecular Medicine

    doi: 10.3892/ijmm.2018.3646

    Protein expression of VEGF and PEDF in the xanthatin group and the control group. (A) Representative fluorescence microscopy images showing expression of VEGF and PEDF and their localization in the alkali-burned rat corneas of the xanthatin treatment group and the control group on day 14. (B) Quantification of expression levels of VEGF and PEDF in the xanthatin treatment group and the control group was performed using ImageJ software. (C) Western blot bands of protein expression of VEGF and PEDF in the alkali-burned rat corneas of the xanthatin treatment group and the control group on day 14 are shown. (D) Histograms representing the relative levels of VEGF and PEDF, respectively, in the xanthatin treatment group and the control group. Data are presented as the mean ± standard deviation from three independent experiments. * P
    Figure Legend Snippet: Protein expression of VEGF and PEDF in the xanthatin group and the control group. (A) Representative fluorescence microscopy images showing expression of VEGF and PEDF and their localization in the alkali-burned rat corneas of the xanthatin treatment group and the control group on day 14. (B) Quantification of expression levels of VEGF and PEDF in the xanthatin treatment group and the control group was performed using ImageJ software. (C) Western blot bands of protein expression of VEGF and PEDF in the alkali-burned rat corneas of the xanthatin treatment group and the control group on day 14 are shown. (D) Histograms representing the relative levels of VEGF and PEDF, respectively, in the xanthatin treatment group and the control group. Data are presented as the mean ± standard deviation from three independent experiments. * P

    Techniques Used: Expressing, Fluorescence, Microscopy, Software, Western Blot, Standard Deviation

    2) Product Images from "Xanthatin inhibits corneal neovascularization by inhibiting the VEGFR2-mediated STAT3/PI3K/Akt signaling pathway"

    Article Title: Xanthatin inhibits corneal neovascularization by inhibiting the VEGFR2-mediated STAT3/PI3K/Akt signaling pathway

    Journal: International Journal of Molecular Medicine

    doi: 10.3892/ijmm.2018.3646

    Protein expression of VEGF and PEDF in the xanthatin group and the control group. (A) Representative fluorescence microscopy images showing expression of VEGF and PEDF and their localization in the alkali-burned rat corneas of the xanthatin treatment group and the control group on day 14. (B) Quantification of expression levels of VEGF and PEDF in the xanthatin treatment group and the control group was performed using ImageJ software. (C) Western blot bands of protein expression of VEGF and PEDF in the alkali-burned rat corneas of the xanthatin treatment group and the control group on day 14 are shown. (D) Histograms representing the relative levels of VEGF and PEDF, respectively, in the xanthatin treatment group and the control group. Data are presented as the mean ± standard deviation from three independent experiments. * P
    Figure Legend Snippet: Protein expression of VEGF and PEDF in the xanthatin group and the control group. (A) Representative fluorescence microscopy images showing expression of VEGF and PEDF and their localization in the alkali-burned rat corneas of the xanthatin treatment group and the control group on day 14. (B) Quantification of expression levels of VEGF and PEDF in the xanthatin treatment group and the control group was performed using ImageJ software. (C) Western blot bands of protein expression of VEGF and PEDF in the alkali-burned rat corneas of the xanthatin treatment group and the control group on day 14 are shown. (D) Histograms representing the relative levels of VEGF and PEDF, respectively, in the xanthatin treatment group and the control group. Data are presented as the mean ± standard deviation from three independent experiments. * P

    Techniques Used: Expressing, Fluorescence, Microscopy, Software, Western Blot, Standard Deviation

    3) Product Images from "Intestinal Alkaline Phosphatase Inhibits the Translocation of Bacteria of Gut-Origin in Mice with Peritonitis: Mechanism of Action"

    Article Title: Intestinal Alkaline Phosphatase Inhibits the Translocation of Bacteria of Gut-Origin in Mice with Peritonitis: Mechanism of Action

    Journal: PLoS ONE

    doi: 10.1371/journal.pone.0124835

    Activity of the VEGF promoter and the Claudin-2 promoter in Caco-2 cells treated with IAP. A: The DNA binding domains of SP-1 and Cdx-1 respectively. B: The ChIP assay was performed to examine the DNA-binding activity of SP1 to the VEGF promoter and of Cdx-2 to the Claudin-2 promoter in Caco-2 cells receiving varying IAP treatments. C: The quantification of SP1 and VEGF promoter PCR data; the data were analyzed using the Image J software.
    Figure Legend Snippet: Activity of the VEGF promoter and the Claudin-2 promoter in Caco-2 cells treated with IAP. A: The DNA binding domains of SP-1 and Cdx-1 respectively. B: The ChIP assay was performed to examine the DNA-binding activity of SP1 to the VEGF promoter and of Cdx-2 to the Claudin-2 promoter in Caco-2 cells receiving varying IAP treatments. C: The quantification of SP1 and VEGF promoter PCR data; the data were analyzed using the Image J software.

    Techniques Used: Activity Assay, Binding Assay, Chromatin Immunoprecipitation, Polymerase Chain Reaction, Software

    IAP inhibited VEGF and Claudin-2 expression in Caco-2 cells. Caco-2 cells treated with IAP were used for immunohistochemical analyses of VEGF and Claudin-2. Photomicrographs were taken at 20x magnification.
    Figure Legend Snippet: IAP inhibited VEGF and Claudin-2 expression in Caco-2 cells. Caco-2 cells treated with IAP were used for immunohistochemical analyses of VEGF and Claudin-2. Photomicrographs were taken at 20x magnification.

    Techniques Used: Expressing, Immunohistochemistry

    ERK phosphorylation levels and expression of related proteins following treatment with a phosphatase inhibitor in Caco-2 cells pretreated with IAP. A: Caco-2 cells were treated with varying concentrations of IAP and sodium orthovanadate. Fresh protein samples were extracted from pretreated Caco-2 cells and were subsequently processed for Western blotting assays. Caco-2 cells were treated with increasing concentrations of IAP for 24 h (0, 4, 16 mIU) and with 15mM sodium orthovanadate. Whole-cell proteins were extracted and subjected to Western blotting. Primary antibodies of p-ERK, SP-1, VEGF, Cdx-2 or Claudin-2 were used for the blotting assays. β-actin immunoblotting was performed as an internal loading control. B: The quantification of the proteins Western blotting data; blots were analyzed using the Image J software.
    Figure Legend Snippet: ERK phosphorylation levels and expression of related proteins following treatment with a phosphatase inhibitor in Caco-2 cells pretreated with IAP. A: Caco-2 cells were treated with varying concentrations of IAP and sodium orthovanadate. Fresh protein samples were extracted from pretreated Caco-2 cells and were subsequently processed for Western blotting assays. Caco-2 cells were treated with increasing concentrations of IAP for 24 h (0, 4, 16 mIU) and with 15mM sodium orthovanadate. Whole-cell proteins were extracted and subjected to Western blotting. Primary antibodies of p-ERK, SP-1, VEGF, Cdx-2 or Claudin-2 were used for the blotting assays. β-actin immunoblotting was performed as an internal loading control. B: The quantification of the proteins Western blotting data; blots were analyzed using the Image J software.

    Techniques Used: Expressing, Western Blot, Software

    Changes in protein expression and the time course of the changes in the ERK phosphorylation in Caco-2 cells pretreated with IAP. A: Caco-2 cells were treated with increasing concentrations of IAP for 48 h (0, 4, 16 mIU). Whole-cell protein were extracted and subjected to Western blotting. Primary antibodies of ERK, p-ERK, SP-1, VEGF, Cdx-2 or Claudin-2 were used for the blotting assays. β-Actin immunoblotting was performed as an internal loading control. B: Caco-2 cells were treated with 16 mIU IAP for varying lengths of time (0, 0.5, 2 or 4 h). Upper figure, levels of phosphorylated ERK detected by Western blotting. C: The quantification of ERK and p-ERK Western blotting data of the dose-cause; blots were analyzed using the Image J software. D: The quantification of other proteins Western blotting data of the dose-cause; blots were analyzed using the Image J software. E: The quantification of ERK and p-ERK Western blotting data of the time-cause; blots were analyzed using the Image J software.
    Figure Legend Snippet: Changes in protein expression and the time course of the changes in the ERK phosphorylation in Caco-2 cells pretreated with IAP. A: Caco-2 cells were treated with increasing concentrations of IAP for 48 h (0, 4, 16 mIU). Whole-cell protein were extracted and subjected to Western blotting. Primary antibodies of ERK, p-ERK, SP-1, VEGF, Cdx-2 or Claudin-2 were used for the blotting assays. β-Actin immunoblotting was performed as an internal loading control. B: Caco-2 cells were treated with 16 mIU IAP for varying lengths of time (0, 0.5, 2 or 4 h). Upper figure, levels of phosphorylated ERK detected by Western blotting. C: The quantification of ERK and p-ERK Western blotting data of the dose-cause; blots were analyzed using the Image J software. D: The quantification of other proteins Western blotting data of the dose-cause; blots were analyzed using the Image J software. E: The quantification of ERK and p-ERK Western blotting data of the time-cause; blots were analyzed using the Image J software.

    Techniques Used: Expressing, Western Blot, Software

    Related Articles

    Incubation:

    Article Title: RABEX-5 Is Upregulated and Plays an Oncogenic Role in Gastric Cancer Development by Activating the VEGF Signaling Pathway
    Article Snippet: Endogenous peroxidase activity was inhibited following incubation with methanol containing 0.3% H2 O2 for 30 min. .. Sections were then incubated with antibodies detecting RABEX-5 (1∶50, Santa Cruz Biotechnology, USA) or VEGF (1∶150; Ab46154, Abcam, USA) at 4°C overnight. ..

    Article Title: HIF-1-VEGF-Notch mediates angiogenesis in temporomandibular joint osteoarthritis
    Article Snippet: .. Microwave treated antigen retrieval was performed and non-specific binding was blocked using goat serum for 30 min, and the slides were then incubated overnight at 4°C with primary antibodies including those that HIF-1α (Novus Biological, NB100-449, USA), Cleaved Notch-1 [Notch-1 intracellular domain, NICD (Cell Signaling Technology, #2421, USA)] and VEGF (Abcam, ab46154, USA). .. Antibody binding was localized using a secondary biotin-labeled anti-rabbit antibody and the streptavidin-conjugated horseradish peroxidase (Bohai biotechnology, China), and revealed using 3, 3’-diaminobenzidine as the chromogenic substrate for peroxidase.

    Immunohistochemistry:

    Article Title: Beyond proliferation: KLF5 promotes angiogenesis of bladder cancer through directly regulating VEGFA transcription
    Article Snippet: Immunohistochemistry Tumor sections of bladder cancer patients or nude mice xenografts were studied by immunohistochemistry (IHC) assay using EnVisionTM System (DAKO, Carpinteria, CA, USA). .. Primary antibodies used in IHC were KLF5 (Abcam, ab24331, 1:200), PCNA (Santa Cruz, sc-7907, 1:300), VEGFA (Abcam, ab46154, 1:150) and CD31 (Epitomics, 2530-1, 1:100). .. Staining signals were photographed using an Olympus BX51 Microscope (Olympus, Tokyo, Japan).

    Western Blot:

    Article Title: FOXP3 inhibits angiogenesis by downregulating VEGF in breast cancer
    Article Snippet: .. Western blot analysis In brief, samples were separated by SDS-PAGE, blotted onto polyvinylidene fluoride (PVDF) membranes and probed with primary antibodies against FOXP3 (ab22510, Abcam, 1:500 dilution) or VEGF (ab46154, Abcam, 1:500 dilution) and a secondary HRP-conjugated IgG antibody. .. Enhanced chemiluminescence (Thermo Fisher, Waltham, MA, USA) for HRP was used to visualize immunoreactive protein.

    SDS Page:

    Article Title: FOXP3 inhibits angiogenesis by downregulating VEGF in breast cancer
    Article Snippet: .. Western blot analysis In brief, samples were separated by SDS-PAGE, blotted onto polyvinylidene fluoride (PVDF) membranes and probed with primary antibodies against FOXP3 (ab22510, Abcam, 1:500 dilution) or VEGF (ab46154, Abcam, 1:500 dilution) and a secondary HRP-conjugated IgG antibody. .. Enhanced chemiluminescence (Thermo Fisher, Waltham, MA, USA) for HRP was used to visualize immunoreactive protein.

    Binding Assay:

    Article Title: HIF-1-VEGF-Notch mediates angiogenesis in temporomandibular joint osteoarthritis
    Article Snippet: .. Microwave treated antigen retrieval was performed and non-specific binding was blocked using goat serum for 30 min, and the slides were then incubated overnight at 4°C with primary antibodies including those that HIF-1α (Novus Biological, NB100-449, USA), Cleaved Notch-1 [Notch-1 intracellular domain, NICD (Cell Signaling Technology, #2421, USA)] and VEGF (Abcam, ab46154, USA). .. Antibody binding was localized using a secondary biotin-labeled anti-rabbit antibody and the streptavidin-conjugated horseradish peroxidase (Bohai biotechnology, China), and revealed using 3, 3’-diaminobenzidine as the chromogenic substrate for peroxidase.

    Similar Products

  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93
    Abcam phosphorylated vegfr 2
    Acute ethanol exposure decreases VEGF receptor <t>(VEGFR)-2</t> RNA expression in vitro. Murine endothelial cells (SVEC4-10) were incubated without or with VEGF (100 ng/ml) in the presence or absence of ethanol (100 mg/dl) for 4, 8, or 24 h under normoxic or
    Phosphorylated Vegfr 2, supplied by Abcam, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/phosphorylated vegfr 2/product/Abcam
    Average 93 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    phosphorylated vegfr 2 - by Bioz Stars, 2021-04
    93/100 stars
      Buy from Supplier

    96
    Abcam antibodies against vegf a
    <t>VEGF-A</t> expression is activated in the retinas of OIR mice. (A) Immunoblot analysis of the protein expression levels of VEGF-A and HIF-1α in the retinas. (B) Quantification revealed an increase in the expression levels of VEGF-A and HIF-1α in the retinas of the OIR mice compared with WT mice. The relative protein expression level was normalized to GAPDH (n=3 mice per group). Data are presented as the mean ± standard deviation of the mean. *P
    Antibodies Against Vegf A, supplied by Abcam, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/antibodies against vegf a/product/Abcam
    Average 96 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    antibodies against vegf a - by Bioz Stars, 2021-04
    96/100 stars
      Buy from Supplier

    97
    Abcam vascular endothelial growth factor vegf
    Immunophenotyping by flow cytometry. Positive expression for cytoskeletal markers (cytokeratin and β-tubulin) and most mesenchymal cell markers (Stro-1, CD90 and CD105). High levels of expression for vascular endothelial growth factor marker <t>(VEGF),</t> hematopoietic precursor cell marker (CD117), and negative response for hematopoietic cells (CD34) and neural precursor cells (Nestin); expression of markers for ciliated cells (Myosin VIIa) and pluripotent cells (Sox-2 and Oct-4)
    Vascular Endothelial Growth Factor Vegf, supplied by Abcam, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/vascular endothelial growth factor vegf/product/Abcam
    Average 97 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    vascular endothelial growth factor vegf - by Bioz Stars, 2021-04
    97/100 stars
      Buy from Supplier

    94
    Abcam mouse vegf c protein
    Lymphatic regeneration correlates with expression of <t>VEGF-C</t>
    Mouse Vegf C Protein, supplied by Abcam, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse vegf c protein/product/Abcam
    Average 94 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    mouse vegf c protein - by Bioz Stars, 2021-04
    94/100 stars
      Buy from Supplier

    Image Search Results


    Acute ethanol exposure decreases VEGF receptor (VEGFR)-2 RNA expression in vitro. Murine endothelial cells (SVEC4-10) were incubated without or with VEGF (100 ng/ml) in the presence or absence of ethanol (100 mg/dl) for 4, 8, or 24 h under normoxic or

    Journal:

    Article Title: Acute ethanol exposure disrupts VEGF receptor cell signaling in endothelial cells

    doi: 10.1152/ajpheart.00699.2007

    Figure Lengend Snippet: Acute ethanol exposure decreases VEGF receptor (VEGFR)-2 RNA expression in vitro. Murine endothelial cells (SVEC4-10) were incubated without or with VEGF (100 ng/ml) in the presence or absence of ethanol (100 mg/dl) for 4, 8, or 24 h under normoxic or

    Article Snippet: Incubation in primary antibody against phosphorylated VEGFR-2 at 1:1,000 (ab5472, Abcam) or GAPDH at 1:5,000 (Fitzgerald Industries, Concord, MA) was performed in 5% bovine serum albumin overnight at 4°C.

    Techniques: RNA Expression, In Vitro, Incubation

    Acute ethanol exposure decreases phosphorylation of VEGFR-2 in vitro. Murine endothelial cells (SVEC4-10) were incubated without or with VEGF (100 ng/ml) in the presence or absence of ethanol (100 mg/dl) for 5 min. Total protein (150 μg) from

    Journal:

    Article Title: Acute ethanol exposure disrupts VEGF receptor cell signaling in endothelial cells

    doi: 10.1152/ajpheart.00699.2007

    Figure Lengend Snippet: Acute ethanol exposure decreases phosphorylation of VEGFR-2 in vitro. Murine endothelial cells (SVEC4-10) were incubated without or with VEGF (100 ng/ml) in the presence or absence of ethanol (100 mg/dl) for 5 min. Total protein (150 μg) from

    Article Snippet: Incubation in primary antibody against phosphorylated VEGFR-2 at 1:1,000 (ab5472, Abcam) or GAPDH at 1:5,000 (Fitzgerald Industries, Concord, MA) was performed in 5% bovine serum albumin overnight at 4°C.

    Techniques: In Vitro, Incubation

    VEGF-A expression is activated in the retinas of OIR mice. (A) Immunoblot analysis of the protein expression levels of VEGF-A and HIF-1α in the retinas. (B) Quantification revealed an increase in the expression levels of VEGF-A and HIF-1α in the retinas of the OIR mice compared with WT mice. The relative protein expression level was normalized to GAPDH (n=3 mice per group). Data are presented as the mean ± standard deviation of the mean. *P

    Journal: Molecular Medicine Reports

    Article Title: Oxidative stress, autophagy and pyroptosis in the neovascularization of oxygen-induced retinopathy in mice

    doi: 10.3892/mmr.2018.9759

    Figure Lengend Snippet: VEGF-A expression is activated in the retinas of OIR mice. (A) Immunoblot analysis of the protein expression levels of VEGF-A and HIF-1α in the retinas. (B) Quantification revealed an increase in the expression levels of VEGF-A and HIF-1α in the retinas of the OIR mice compared with WT mice. The relative protein expression level was normalized to GAPDH (n=3 mice per group). Data are presented as the mean ± standard deviation of the mean. *P

    Article Snippet: Following electrophoresis and wet transfer to a polyvinylidene difluoride (PVDF) membrane, the membrane was blocked in 5% skim milk in TBS with Tween-20 (TBST) at room temperature for 1 h. Immunostaining was conducted using antibodies against VEGF-A (cat. no. ab52917; 1:500), caspase-1 (cat. no. ab1872; 1:1,000), pro-caspase-1 (cat. no. ab179515; 1:1,000), interleukin (IL)-1β (cat. no. ab2105; 1:500), pro-IL-1β (cat. no. ab2105; 1:500), microtubule associated protein 1 light chain 3α (LC3; cat. no. ab48394; 1:500) (Abcam, Cambridge, MA, USA), HIF-1α (cat. no. 36169; 1:1,000), autophagy protein (Atg)5 (cat. no. 12994; 1:1,000), Atg7 (cat. no. 8558; 1:1,000), Atg12 (cat. no. 4180; 1:1,000), Beclin1 (cat. no. 3495; 1:1,000), p62 (cat. no. 23214; 1:1,000), NOD-like receptor family pyrin domain-containing 3 (NLRP3; cat. no. 15101; 1:1,000) and GAPDH (cat. no. 5174; 1:1,000; Cell Signaling Technology, Inc, Danvers, MA, USA) at 4°C overnight.

    Techniques: Expressing, Mouse Assay, Standard Deviation

    Immunophenotyping by flow cytometry. Positive expression for cytoskeletal markers (cytokeratin and β-tubulin) and most mesenchymal cell markers (Stro-1, CD90 and CD105). High levels of expression for vascular endothelial growth factor marker (VEGF), hematopoietic precursor cell marker (CD117), and negative response for hematopoietic cells (CD34) and neural precursor cells (Nestin); expression of markers for ciliated cells (Myosin VIIa) and pluripotent cells (Sox-2 and Oct-4)

    Journal: Cytotechnology

    Article Title: Cochlear epithelial of dog fetuses: a new source of multipotent stem cells

    doi: 10.1007/s10616-016-0049-0

    Figure Lengend Snippet: Immunophenotyping by flow cytometry. Positive expression for cytoskeletal markers (cytokeratin and β-tubulin) and most mesenchymal cell markers (Stro-1, CD90 and CD105). High levels of expression for vascular endothelial growth factor marker (VEGF), hematopoietic precursor cell marker (CD117), and negative response for hematopoietic cells (CD34) and neural precursor cells (Nestin); expression of markers for ciliated cells (Myosin VIIa) and pluripotent cells (Sox-2 and Oct-4)

    Article Snippet: Primary antibodies included were directed against: markers for pluripotency: Oct-4 (sc-4420, Santa Cruz Biotechnology) and Sox-2 (sc-17320, Santa Cruz Biotechnology); against cytoskeleton markers: Cytokeratin 18 (sc-32329, Santa Cruz Biotechnology) and β-tubulin (sc-47751, Santa Cruz Biotechnology); against the mesenchymal markerss: Stro-1 (sc-47733, Santa Cruz Biotechnology), CD90 (ab225, Abcam, Cambridge, UK) and CD105 (ab53321, Abcam); against the neuronal progenitor cell marker Nestin (sc-33677, Santa Cruz Biotechnology); against the vascular endothelial growth factor VEGF (ab1316, Abcam); against the marker for ciliated cells Myosin VIIa (ab3481, Abcam); against the marker for hematopoietic precursor cells CD117 (A4502, Dako Cytomation); against the marker for hematopoietic cells CD34 (BD555824, Becton Dickinson, San Jose, CA, USA).

    Techniques: Flow Cytometry, Cytometry, Expressing, Marker

    Lymphatic regeneration correlates with expression of VEGF-C

    Journal: Plastic and reconstructive surgery

    Article Title: Lymph Node Transplantation Results in Spontaneous Lymphatic Reconnection and Restoration of Lymphatic Flow

    doi: 10.1097/01.prs.0000436840.69752.7e

    Figure Lengend Snippet: Lymphatic regeneration correlates with expression of VEGF-C

    Article Snippet: In order to determine if immune cells survive after lymph node transfer, we stained harvested lymph nodes with an antibody directed against T cells (CD3) or B cells (B220); Abcam, Cambridge MA). ( ) To determine if endogenously expressed VEGF-C expression correlates with lymphatic regeneration after lymph node transplant, we stained freshly frozen lymph nodes with an antibody against the mouse VEGF-C protein (Abcam, Cambridge, MA). ( ) Although the mechanisms by which lymph node transfers ameliorate lymphedema remain unknown, one hypothesis is that lymphatic fluid is filtered through lymphatic vessels into adjacent high endothelial vessels (HEVs) of the lymph node, thereby shifting the fluid to vascular compartment. ( ) Therefore, to examine potential interactions between lymphatic and vascular systems, we co-stained harvested lymph node specimens for LYVE-1 and MECA32 to identify lymphatic vessels and HEVs, respectively. ( )

    Techniques: Expressing